Stay updated on CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial page.

Latest updates to the CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe new screenshot shows only minor visual/layout adjustments to the Record History page; core study details and statuses appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check32 days agoChange DetectedCore content updated: adds a funding-related operating-status notice and confirms NIH Clinical Center is open, plus a version upgrade to v3.2.0 and removal of v3.1.0.SummaryDifference10%

- Check39 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.2%

- Check53 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' element; core content and pricing/time-related information remain unchanged.SummaryDifference0.6%

- Check60 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.6%

- Check68 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and listed countries. These changes enhance the clarity of the page's content regarding study status and recruitment.SummaryDifference41%

Stay in the know with updates to CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial page.